News from pdl biopharma, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 04, 2015, 16:02 ET

PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the: - 3.75% Convertible Senior Notes due May...

Mar 03, 2015, 07:00 ET

PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit

 PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that the third of three shareholder lawsuits filed in the fall of...

Feb 26, 2015, 07:00 ET

PDL BioPharma to Hold Annual Meeting of Stockholders on May 28, 2015

 PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that the Company will hold its annual meeting of stockholders on...

Feb 23, 2015, 16:07 ET

PDL BioPharma Announces Fourth Quarter and Full Year 2014 Financial Results

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the fourth quarter and year ended December 31, 2014. Total...

Feb 17, 2015, 07:00 ET

PDL BioPharma to Announce Fourth Quarter and Full Year 2014 Financial Results on February 23, 2015

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its fourth quarter and full year 2014 financial results...

Feb 04, 2015, 07:00 ET

PDL BioPharma to Present at Upcoming Investor Conferences

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will...

Jan 29, 2015, 07:00 ET

PDL BioPharma Announces 2015 Regular Quarterly Dividends

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that its board of directors has declared that the regular, quarterly dividends to be...

Dec 15, 2014, 16:02 ET

PDL BioPharma Completes Regular Quarterly Dividend Payment

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the December 12, 2014, regular quarterly dividend payment of $0.15...

Dec 10, 2014, 16:02 ET

PDL BioPharma Provides Fourth Quarter 2014 Revenue Guidance of $158 Million

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced revenue guidance for the fourth quarter ending December 31, 2014, of approximately...

Dec 04, 2014, 16:01 ET

PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the: - 3.75% Convertible Senior Notes...

Nov 18, 2014, 07:00 ET

PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics

PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that in connection with the acquisition of Durata Therapeutics, Inc. by Actavis, PDL has...

Nov 14, 2014, 07:00 ET

PDL BioPharma Announces Successful Conclusion of Revenue Interest Agreement with AxoGen

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company has received $30.3 million, in addition to previously received...

Nov 12, 2014, 07:00 ET

PDL BioPharma to Present at Jefferies 2014 Global Healthcare Conference

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that company management will present at the Jefferies 2014 Global Healthcare...

Nov 10, 2014, 16:02 ET

PDL BioPharma Announces Third Quarter 2014 and Year to Date Financial Results

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the third quarter and nine months ended September 30, 2014....

Nov 06, 2014, 16:02 ET

PDL BioPharma Acquires a Portion of the University of Michigan's Royalty Interest in Genzyme's Cerdelga™ (eliglustat) Capsules for $65.6 Million

 PDL BioPharma ("PDL") (Nasdaq: PDLI) announced today that it has acquired a portion of the University of Michigan's ("U-M") worldwide royalty...

Nov 03, 2014, 16:02 ET

PDL BioPharma to Announce Third Quarter 2014 Financial Results on November 10, 2014

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its third quarter 2014 financial results for the period...

Oct 08, 2014, 09:00 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL Announces Appointment of PricewaterhouseCoopers LLP as its New Independent Registered Public Accounting Firm

 PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI), today announced the appointment of PricewaterhouseCoopers LLP ("PwC") as its...

Oct 06, 2014, 07:00 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Bolsters Management Team

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI), today announced two enhancements to the company's management team.  Danny Hart, who has served...

Sep 23, 2014, 09:00 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Responds to Class Action Lawsuit

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI), has been informed of a class action lawsuit filed against the company that alleges violations of...

Sep 17, 2014, 17:57 ET
PDL BioPharma, Inc.  (PRNewsFoto/PDL BioPharma, Inc.)

PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors

 PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) was orally notified by its independent registered accounting firm, Ernst & Young LLP ("EY") that...